As you may know. The standard drug treatment for Parkinson’s contains the amino acid L-dopa (Levadopa) and Carbidopa. L-dopa can cross over into the brain and increase the amount of dopamine calming down the symptoms of Parkinson’s. Carbidopa is only added to stop nausea caused by L-dopa. However, this drug combination leads to the significant site effects and progressive deterioration of the individual suffering from Parkinson’s. Site effects include low blood pressure, arrhythmia, gastrointestinal bleeding, disorientation, confusion, hallucinations and premature death (to name a few).
What if we discovered a way to allow very high doses of L-dopa with out generating any side effects?
What if on top of that, this approach could also stopped the destruction of the dopamine-producing cells?
Well, thanks to a very innovative thinking of the medical research team now we have.
For 16 years Dr. Ross Stewart has been working with Dr. Marty Hinz, MD on the clinical application of this very effective medically developed non-pharmaceutical protocol.
Parkinson’s disease is associated with depletion of:
- Thiols(homocysteine, L-methionine, S-adenosyl-L-methionine, S-adenosyl-homocysteine, Cystathione, L-cysteine, and glutathione)
- L- tryptophan
These depletion’s represent relative nutritional deficiencies (RNDs) where systemic nutritional synthesis requirements cannot be achieved on a normal or optimal diet.
L-dopa has the ability to induce nutritional deficiency of:
L-dopa (nutrient) is the most effective Parkinson’s disease treatment there is. Unfortunately nearly one-million United States Parkinson’s victoms take L-dopa (Levadopa) with Carbidopa every day.
Carbidopa does not treat the symptoms of Parkinson’s disease. It is used to control L-dopa-induced nausea. Vitamin B6 is involved in more chemical reactions in the body than any other nutrient. Carbidopa irreversibly binds to and permanently deactivates vitamin B6 and the B6-dependent enzymes. This compromises the function of over 300 enzymes and proteins in the body.
Carbidopa depletes the B6 taken in with food and the B6 reserves of the body. The B6 reserve in the body is huge. It is composed of the B6 which is reversibly bound to about 300 enzymes and proteins. B6 DEPLETION contributes to the increasing Parkinson’s disease death rate. B6 DEPLETION symptoms may be wrongly attributed to the neurodegeneration of Parkinson’s disease. B6 DEPLETION cannot be properly managed until the carbidopa is stopped.
Carbidopa is one half of the generic combination L-dopa/carbidopa. The doctor Marty Hinz and his research team discovered and then published the link between the increasing Parkinson’s death rate and carbidopa. Learn the cause of this problem and how to manage it. This approach DOES NOT use carbidopa.
Do Not Be Part Of The Increasing Parkinson’s Disease Death Rate.The Parkinson’s Death Rate has Increased by 328.7% Since 1976 and No One Knows Why (?).
In the the United States one million people have Parkinson’s disease of which 89% take the drug combination L-dopa/carbidopa. According to research done by Dr. Marty Hinz MD and his team Carbidopa does nothing to improve Parkinson’s symptoms. It is only used to control L-dopa-induced nausea. They have discovered how to deal with nausea using nutrients without the risk of side effects associated with Carbidopa.
While the increasing death rate was previously known, nothing had been discovered to change this upward trend. This research was the first to link the drug Carbidopa to the progressive disability and death rate associated with Parkinson’s disease. Carbidopa depletes the vitamin B6 taken in and the B6 reserves of the body. Read: CARBIDOPA AND VITAMIN B6 This paper is peer-reviewed, published in September, 2014.
Researchers also discovered that many late-stage symptoms attributed to progressive Parkinson’s disease are actually due to severe Carbidopa-induced vitamin B6 depletion along with other nutritional deficiencies. Correcting the problem cannot be done until the Carbidopa is stopped. This is something that needs to be done under the supervision of a prescribing doctor. Stopping Carbidopa usually causes L-dopa-induced nausea and vomiting. In 2009, Dr. Marty Hinz MD. and his team perfected administration of nutrients which is highly effective in alleviating nausea while simultaneously treating the known nutritional deficiencies associated with Parkinson’s disease.
Pioneering medical doctors lead by Dr. Marty Hinz MD. discovered then published an alternative L-dopa approach without Carbidopa. This is not a new treatment! It is simply based on L-dopa, a nutrient normally found in the human body. L-dopa is the most effective treatment for Parkinson’s disease and when it is administered in proper balance with other nutrients, there are no unmanageable side effects.
When used as a nutrient L-dopa will build the system up. When used as a drug L-dopa destroys the system, causing side effects and deterioration.
This pioneering medical research, started in 1994 by Marty Hinz, MD, has demonstrated that most of the late stage Parkinson’s degeneration is not from the disease. Rather, it is caused by the unbalanced way L-dopa is administered which depletes multiple nutrition-based systems along with Carbidopa’s ability to aggressively deplete vitamin B6.
The medical doctors invented, developed and refined a safe nutrient approach for the administration of L-dopa without Carbidopa that reverses nutritional collapse. They published their findings in 2014. This pioneering medical research, is the most important advance in Parkinson’s disease treatment in over 50 years.
Administrating L-dopa (with or without Carbidopa) causes depletion of tyrosine, thiols (sulfur-containing amino acids) serotonin, and tryptophan. Read about the Relative Nutritional Deficiencies resulting from the improper administration of L-dopa, Carbidopa, and other nutrients.
Carbidopa is a drug. It is only given to prevent the nausea caused by L-dopa. It does not improve Parkinson’s disease symptoms. This medical research project by Dr. Marty Hinz and his team was the first to link Carbidopa to the 35 year increasing Parkinson’s death rate. Carbidopa is being taken daily by 89% of the Parkinson’s patients in the United States. It depletes not only all of the vitamin B6 taken in by the patient, it depletes the B6 reserves in the body which potentially compromises the function of over 300 enzymes and proteins that depend on B6. Vitamin B6 cannot be restored while Carbidopa is being taken. THE PARKINSON’S DISEASE DEATH RATE: CARBIDOPA AND VITAMIN B6
This pioneering research allows us to nutritionally support a person suffering from Parkinson’s disease by using L-dopa (nutrient) without carbidopa. The approach restores normal system function on all fronts.
If you would like to change the course of your life, eliminate the need for Parkinson’s drugs that are known to cause serious side effects, you can start this therapy today and begin your journey to a new life with this medically developed and scientifically based protocol clinically proven to eliminate all symptoms of Parkinson’s disease.
To find out how we can help you, please contact our office at:
Here’s how you can Get Started